Efficacy of landiolol hydrochloride for prevention of atrial fibrillation after heart valve surgery

International Heart Journal

Volumn 53, Issue 6, 2012, Pages 359-363

  Sakaguchi, Masanori ^a   Sasaki, Yasuyuki ^a   Hirai, Hidekazu ^a   Hosono, Mitsuharu ^a   Nakahira, Atsushi ^a   Seo, Hiroyuki ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Heart valve disease; Ultra short acting blocker

Indexed keywords

AMLODIPINE; BENIDIPINE; DILTIAZEM; LANDIOLOL; NIFEDIPINE; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE; MORPHOLINE DERIVATIVE; UREA;

AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART INDEX; HEART RATE; HEART VALVE SURGERY; HUMAN; LUNG ARTERY PRESSURE; MALE; OPERATION DURATION; POSTOPERATIVE PERIOD; PREMEDICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SURGICAL RISK; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP; HEART VALVE REPLACEMENT; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UREA;

EID: 84873740091     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.53.359     Document Type: Article

References (28)

1. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-73. (Review)
2. Hogue CW Jr, Creswell LL, Gutterman DD, Fleisher LA. Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128: 9S-16S. (Review)
3. Shiroya T, Ichioka Y, Yoshida K, et al. Pharmacological studies of ONO-1101 as a β-blocking agent with high β1-selectivity and ultra-short duration of action. Kiso to Rinsho 1997; 31: 2913-23.
4. Nakajima M, Kanemaru M. Phase I study of ONO-1101, a new ultra short acting β1-blocking agent in healthy volunteers. Rinsho Iyaku 2000; 16: 1531-56.
5. Fujiwara H, Sakurai M, Namai A, Kawamura T. Effect of lowdose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation after CABG surgery. Gen Thorac Cardiovasc Surg 2009; 57: 132-7.
6. Tanaka K. Effects of landiolol on hemodynamic improvement and prevention of atrial fibrillation in the perioperative period of offpump coronary artery bypass grafting. Kyobu Geka 2010; 63: 175-9. (Japanese)
7. Iwasawa K, Nakagawa H, Kato M, et al. Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting. Masui 2005; 54: 402-7. (Japanese)
8. Sezai A, Minami K, Nakai T, et al. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. J Thorac Cardiovasc Surg 2011; 141: 1478-87.
9. Shimomura T, Usui A, Ueda Y. Involvement of sympathetic activity in the onset of atrial fibrillation following cardiac surgery. Jpn J Cardiovasc Surg 2006; 35: 309-14.
10. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006; 48: 854-906.
11. Martinez EA, Epstein AE, Bass EB. Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005; 128(2 Suppl): 56S-60S.
12. Wakamatsu H, Takase S, Sato Y, Seto Y, Kurosawa H, Yokoyama H. Effect of intra-operative low-dose infusion of landiolol hydrochloride on post-operative atrial fibrillation after off-pump coronary artery bypass grafting. Kyobu Geka 2010; 63: 764-8. (Japanese)
13. Nishizaki K, Hatada K, Tamura Y, Seki T. Rate control with landiolol for atrial tachycardia following cardiovascular surgery. J New Rem & Clin 2008; 57: 331-7.
14. Sugiura T, Koide M, Kunii Y, Umehara N, Watanabe K. Effect of ultra-short-acting β-blocker landiolol after cardiovascular surgery. Jpn J Cardiovasc Surg 2009; 38: 179-83.
15. Uehara K, Ueyama K, Ito H, et al. Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone? Kyobu Geka 2010; 63: 188-91. (Japanese)
16. Goto K, Shingu C, Miyamoto S, Miyakawa H, Noguchi T. The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease. J Clin Anesth 2007; 19: 523-9.
17. Ikeshita K, Nishikawa K, Toriyama S, et al. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth 2008; 22: 361-6.
18. Sasao J, Tarver SD, Kindscher JD, Taneyama C, Benson KT, Goto H. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol. Can J Anaesth 2001; 48: 985-9.
19. Morisaki A, Hosono M, Sasaki Y, et al. Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function. Gen Thorac Cardiovasc Surg 2012; 60: 386-90.
20. Zaman AG, Archbold RA, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation 2000; 101: 1403-8.
21. Amar D, Shi W, Hogue CW Jr, et al. Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting. J Am Coll Cardiol 2004; 44: 1248-53.
22. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-9.
23. Nakagawa H, Kataoka H, Kawahara K, Goto N. Effects of nitrendipine, benidipine and amlodipine on regional blood flow and vascular resistance in conscious spontaneously hypertensive rats. Clinical Report 1996; 30: 339-47.
24. Sato M, Murata S, Narita H, Tomita M, Yamashita K, Yamaguchi I. Hypotensive effects of diltiazem hydrochloride in the normotensive, spontaneously hypertensive and renal hypertensive rats. Nihon Yakurigaku Zasshi 1979; 75: 99-106. (Japanese)
25. Seitelberger R, Hannes W, Gleichauf M, Keilich M, Christoph M, Fasol R. Effects of diltiazem on perioperative ischemia, arrhythmias, and myocardial function in patients undergoing elective coronary bypass grafting. J Thorac Cardiovasc Surg 1994; 107: 811-21.
26. Bénardeau A, Fareh S, Nattel S. Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs. Cardiovasc Res 2001; 50: 85-96.
27. Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther 2005; 27: 1963-9.
28. Halonen J, Hakala T, Auvinen T, et al. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation 2006; 114: I1-4.